Chilblains-like lesions and SARS-CoV-2 in children: An overview in therapeutic approach.
coronavirus disease 2019
pediatricssevere acute respiratory syndrome-Coronavirus type-2
therapy
Journal
Dermatologic therapy
ISSN: 1529-8019
Titre abrégé: Dermatol Ther
Pays: United States
ID NLM: 9700070
Informations de publication
Date de publication:
Jan 2021
Jan 2021
Historique:
received:
29
09
2020
revised:
20
10
2020
accepted:
29
10
2020
pubmed:
4
11
2020
medline:
27
2
2021
entrez:
3
11
2020
Statut:
ppublish
Résumé
SARS-CoV-2 (Severe Acute Respiratory Syndrome, Coronavirus, type 2) is the virus responsible for the global pandemic of Coronavirus disease 2019 (COVID-19) that began in China in December 2019. The variability of nasal olfactory symptoms in pediatric patients is interlinked with possible warning signs, including respiratory, gastrointestinal, ocular, or dermatological symptoms. Skin findings in patients with COVID-19 can range from petechiae to papulovesicular rashes to diffuse urticaria and can be confused with rashes of non-COVID-19 conditions. These lesions typically appear early during COVID-19 and are thought to be secondary to viral replication or circulating cytokines. Herein, we discuss two pediatric cases, presenting with skin lesions, which tested positive for SARS-CoV-2, thus, briefly reviewing current literature for similar reports and related management. Although these lesions heal spontaneously in most cases, an adequate "targeted" therapeutic approach can shorten the time and the discomfort of the skin disease.
Types de publication
Journal Article
Review
Langues
eng
Sous-ensembles de citation
IM
Pagination
e14502Informations de copyright
© 2020 Wiley Periodicals LLC.
Références
Pavone P, Ceccarelli M, Taibi R, La Rocca G, Nunnari G. Outbreak of COVID-19 infection in children: fear and serenity. Eur Rev Med Pharmacol Sci. 2020;24:4572-4575.
Zimmermann P, Curtis N. Coronavirus infections in children including COVID-19: an overview of the epidemiology, clinical features, diagnosis, treatment and prevention options in children. Pediatr Infect Dis J. 2020;39(5):355-368. https://doi.org/10.1097/INF.0000000000002660.
Dong Y, Mo X, Hu Y, et al. Epidemiology of COVID-19 Among Children in China. Pediatrics. 2020;145(6):e20200702. http://dx.doi.org/10.1542/peds.2020-0702.
Li Q, Guan X, Wu P, et al. Early transmission dynamics in Wuhan, China, of novel coronavirus-infected pneumonia. N Engl J Med. 2020; 382(13):1199-1207. https://doi.org/10.1056/NEJMoa2001316.
Heymann DL, Shindo N. WHO scientific and technical advisory group for infectious hazards. COVID-19: what is next for public health? Lancet. 2020;395:542-545.
Kotlyar AM, Grechukhina O, Chen A, et al. Vertical transmission of coronavirus disease 2019: a systematic review and meta-analysis. Am J Obstet Gynecol. 2020;49:1-19. https://doi.org/10.1016/j.ajog.2020.07.049
Chen ZM, Fu JF, Shu Q, et al. Diagnosis and treatment recommendations for pediatric respiratory infection caused by the 2019 novel coronavirus. World J Pediatr. 2020;16(3):240-246. https://dx.doi.org/10.1007/s12519-020-00345-5.
Shen KL Kunling, Yang YH, Wang TY, et al. Diagnosis, treatment, and prevention of 2019 novel coronavirus infection in children: experts’ consensus statement. World Journal of Pediatrics. 2020;16(3):223-231. http://dx.doi.org/10.1007/s12519-020-00343-7.
Molloy EJ, Bearer CF. COVID-19 in children and altered inflammatory responses. Pediatr Res. 2020;88:340-341. https://doi.org/10.1038/s41390-020-0881-y.
Genovese G, Colonna C, Marzano AV. Varicella-like exanthem associated with COVID-19 in an 8-year-old girl: a diagnostic clue? Pediatr Dermatol. 2020;37:435-436. https://doi.org/10.1111/pde.14201.
Diotallevi F, Campanati A, Bianchelli T, et al. Skin involvement in SARS-CoV-2 infection: case series. J Med Virol. 2020;92:2332-2334. https://doi.org/10.1002/jmv.26012.
Guarneri C, Venanzi Rullo E, Gallizzi R, et al. Diversity of clinical appearance of cutaneous manifestations in the course of COVID-19. Journal of the European Academy of Dermatology and Venereology. 2020;34(9):1-6. http://dx.doi.org/10.1111/jdv.16669.
Pavone P, Giallongo A, La Rocca A, et al. Recent COVID-19 outbreak: effects in childhood. Infect Dis Trop Med. 2020;6:e594.
Huang C, Wang Y, Li X, et al. Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China. Lancet. 2020;395(10223):497-506. https://doi.org/10.1016/S0140-6736(20)30183-5.
Zheng F, Liao C, Fan QH, et al. Clinical characteristics of children with coronavirus disease 2019 in Hubei, China. Curr Med Sci. 2020;40(2):275-280. https://doi.org/10.1007/s11596-020-2172-6.
Guarneri C, Rullo EV, Pavone P, et al. Silent COVID-19: what your skin can reveal. Lancet Infect Dis. 2020;3099(20):30402-30403. https://doi.org/10.1016/S1473-3099(20)30402-3.
Gallizzi R, Sutera D, Spagnolo A, et al. Management of pernio-like cutaneous manifestations in children during the outbreak of covid-19. Dermatol Ther. 2020;1-6. e14312. https://doi.org/10.1111/dth.14312.
Recalcati S. Cutaneous manifestations in COVID-19: a first perspective. J Eur Acad Dermatol Venereol. 2020;34(5):212-213. https://doi.org/10.1111/jdv.16387.
Varga Z, Flammer AJ, Steiger P, et al. Endothelial cell infection and endotheliitis in COVID-19. Lancet. 2020;395:1417-1418.
Klimach A, Evans J, Stevens J. Rash as a presenting complaint in a child with COVID-19. Pediatr Dermatol. 2020 37:966-967. https://doi.org/10.1111/PDE.14257.
Torrelo A, Andina D, Santonja C. Erythema multiforme-like lesions in children and COVID-19. Pediatr Dermatol. 2020;37(3):442-446. https://doi.org/10.1111/pde.14246.
Colonna C, Monzani NA, Rocchi A, et al. Chilblain-like lesions in children following suspected COVID-19 infection. Pediatr Dermatol. 2020;37(3):437-440.
Madinaveitia SO, Penedo RP, Gil RR. Lesiones cutáneas en paciente con infección por SARS-COV2. Anal Pediatr. 2020;93(2):144-145.
Ladha MA, Luca N, Constantinescu C. Approach to chilblains during the COVID-19 pandemic. J Cutan Med Surg. 2020;24(5):504-517. https://doi.org/10.1177/1203475420937978.
Perrella A, Carannante N, Berretta M, et al. Novel coronavirus 2019 (Sars-CoV2): a global emergency that needs new approaches? Eur Rev Med Pharmacol Sci. 2020;24(4):2162-2164. https://doi.org/10.26355/eurrev_202002_20396.